Nasus Pharma Ltd · CIK 2029039

Nasus Pharma Ltd

CIK 2029039 · Corporation · Inc. ISRAEL · TEL AVIV, L3 · Biotechnology

https://nasuspharma.com (possible website — auto-inferred, not verified)

Filings

Original notices

Amendments

Activity

Feb 25, 2026
through Feb 25, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot

Form D · Feb 25, 2026

Reported offering amount: $15,000,040
Reported amount sold: $15,000,040

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Contact info

Form D filings (1)

0001493152-26-008057
D · Feb 25, 2026 · Biotechnology

Offering: $15,000,040

Sold: $15,000,040